AEON Biopharma Reports Third Quarter 2025 Results, Including Positive ABP-450 Biosimilarity Data and Strategic Positioning for Continued Growth - AEON
globenewswire.com/news-release/2025/11/14/318...Posted Nov 14, 2025, 1:53 PM UTC
10
globenewswire.com
Loading comments…